Analyst Ratings for CTI BioPharma (CTIC)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/16/2023 | Leerink Partners | Kenneth Shields | Downgrade | Market Perform (Outperform) |
9.10 (13.00) |
8.96 (9.09) |
1.45% | Details |
| 5/11/2023 | Citizens | Reni J. Benjamin | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
4.82 (9.09) |
88.59% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
